ClinicalTrials.gg
CompletedNCT07867756Updated Oct 9, 2026

Comparison of Physical Performance, Quality of Life and Mental Health in Hiking and Sedentary Geriatric Individuals

An observational study in Physical Performance, Quality of Life, and Mental Health in Older Adults, sponsored by Halic University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Halic University · Observational

Updated Oct 9, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
58
Ages
65 Years to 74 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 163 studies in Psychological Well-Being with a site in Turkey — 37 open to participants now, 47 under way, none of them phase 3. Psychological Well-Being · Turkey.

Enrollment
12th of 13
58 · median 208
Started
2025
with 52 others
Observational
13 of 163
none open now
Registered
151st of 163
by date

Among the 163 studies in Psychological Well-Being with a site in Turkey, this one is the 12th largest by enrollment of the 13 observational ones that give a count, is one of 53 that started in 2025, is one of 13 observational ones, and was the 151st registered.

Psychological Well-Being

2,195 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

37 of the 163 studies in Psychological Well-Being with a site in Turkey are open now. Recruiting first, the newest first:

32 more — sign in →

All 37 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 401 Psychological Well-Being studies recruiting now, 218 (54%) set no upper age limit and 157 (39%) stop at 75 or younger; 120 take children under 18; 204 take healthy volunteers.

This study: 65 Years to 74 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 163 studies in Psychological Well-Being with a site in Turkey, or all of them as a file.
02

Study summary

This observational study aims to compare physical performance, quality of life, and mental health levels between older adults who participate in hiking at least once a week for at least 6 months and sedentary older adults. The study includes 58 older adults, with 29 participants in the hiking group and 29 participants in the sedentary group. Physical performance, quality of life, and mental health are assessed using standardized assessment tools.

Read the detailed description

This is a cross-sectional observational study comparing physical performance, quality of life, and mental health levels between older adults who participate in hiking and sedentary older adults.

03

Conditions studied

  • Physical Performance, Quality of Life, and Mental Health in Older Adults

Keywords

  • Hiking, Physical Performance, Quality of Life, Mental Health
04

Who can participate

Ages eligible
65 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of adults aged 65-74 years, including individuals who participate in hiking and sedentary individuals.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hiking Group:

Age between 65 and 74 years. Participating in hiking at least once a week for the past 6 months. (MMSE) score ≥24.

Sedentary Group:

Age between 65 and 74 years. Mini-Mental State Examination (MMSE) score ≥24. No regular recreational physical activity. International Physical Activity Questionnaire (IPAQ) short-form score \<600 MET-min/week (inactive level).

Exclusion criteria

Exclusion Criteria:

  • Rheumatic diseases or joint diseases that limit mobility (such as rheumatoid arthritis, osteoarthritis).

Diseases of the central nervous system (CNS). under active treatment, except for individuals who have not received cancer treatment for at least 1 year.

A diagnosis of major depression.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
58 participants (actual)
Patient registry
No

Groups and cohorts

  • Hiking Group

    Older adults who have participated in hiking at least once a week for the past 6 months.

  • Sedentary Group

    Sedentary older adults who do not regularly participate in physical activity.

06

What researchers measure

Primary outcomes

  1. 2-Minute Step Test

    The 2-Minute Step Test was used to assess physical performance in older adults. Participants were asked to step in place for 2 minutes, raising each knee to a predetermined target height based on the midpoint between the iliac crest and the patella. The number of correctly performed right knee raises reaching the target height during 2 minutes was recorded as the test score. Higher scores indicate better physical performance.

    Time frame: At baseline (single assessment)

Secondary outcomes

  1. Timed Up and Go (TUG) Test - Single Task

    The Timed Up and Go (TUG) test was used to assess functional mobility, dynamic balance, and physical performance. Participants were asked to stand up from a chair, walk 3 meters at their normal pace, turn, walk back to the starting point, and sit down. The time required to complete the test was recorded in seconds. Shorter completion times indicate better performance.

    Time frame: At baseline (single assessment)

  2. Timed Up and Go (TUG) Test - Motor Dual Task

    The Timed Up and Go (TUG) test was performed while participants held a glass filled with water. Participants were asked to stand up from a chair, walk 3 meters while carrying the glass, turn, walk back to the starting point, and sit down while safely holding the glass. The time required to complete the test was recorded in seconds. Shorter completion times indicate better performance.

    Time frame: At baseline (single assessment)

  3. Timed Up and Go (TUG) Test - Motor Dual-Task Cost

    Motor dual-task cost was calculated as the percentage change in TUG completion time between the motor dual-task and single-task conditions using the following formula: (Dual-Task Time - Single-Task Time) / Single-Task Time × 100. Lower dual-task cost indicates better dual-task performance.

    Time frame: At baseline (single assessment)

  4. Timed Up and Go (TUG) Test - Cognitive Dual Task

    The Timed Up and Go (TUG) test was performed while participants counted backward by threes from 100. Participants were asked to stand up from a chair, walk 3 meters while counting backward, turn, walk back to the starting point, and sit down. The time required to complete the test was recorded in seconds. Shorter completion times indicate better performance.

    Time frame: At baseline (single assessment)

  5. Timed Up and Go (TUG) Test - Cognitive Dual-Task Cost

    Cognitive dual-task cost was calculated as the percentage change in TUG completion time between the cognitive dual-task and single-task conditions using the following formula: (Dual-Task Time - Single-Task Time) / Single-Task Time × 100. Lower dual-task cost indicates better dual-task performance.

    Time frame: At baseline (single assessment)

  6. World Health Organization Quality of Life - Older Adults Module (WHOQOL-OLD)

    The WHOQOL-OLD module was used to assess quality of life in older adults. The questionnaire consists of 24 items across six dimensions: sensory abilities, autonomy, past, present and future activities, social participation, death and dying, and intimacy. Each item is scored on a 5-point Likert scale, and the total score ranges from 24 to 120. Higher scores indicate better quality of life.

    Time frame: At baseline (single assessment)

  7. Beck Depression Inventory (BDI)

    The Beck Depression Inventory (BDI) was used to assess depressive symptoms in older adults. The inventory consists of 21 items, with each item scored from 0 to 3. The total score ranges from 0 to 63, with higher scores indicating greater severity of depressive symptoms.

    Time frame: At baseline (single assessment)

07

Study locations

1 site
  • Limyra Dağcılık ve Doğa Sporları Kulübü(LİMDOSK)
    Antalya, Antalya 07100, Turkey (Türkiye)
08

References and documents

Publications

  • Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903. PubMed 10960937 ↗
  • Rikli RE, Jones CJ. Functional fitness normative scores for community-residing older adults, ages 60-94. Journal of Aging and Physical Activity. 1999;7(2):162-181.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Oct 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Oct 9, 2026
StartActual
May 31, 2025
Primary completionActual
Oct 31, 2025
CompletionActual
Oct 31, 2025
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07867756
Lead sponsor
Halic University
Responsible party
Dilek Şahinoğlu (Assistant Professor, Halic University) — Principal investigator
First posted
Oct 9, 2026
Start date
May 31, 2025
Primary completion
Oct 31, 2025
Completion
Oct 31, 2025
Last update
Oct 9, 2026

Study contacts

Dilek ŞAHİNOĞLU, PhD
principal investigator · Halic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion